BAMF Health
PrivateLast Round
Series B
May 4, 2026
Total Funding Raised
$200.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BAMF Health operates in Healthcare & Life Sciences and is based in Grand Rapids, Michigan. Its latest recorded funding round was a Series B round in May 2026.
BAMF Health is a healthcare technology company that operates a vertically integrated platform for intelligence-based precision medicine, specializing in molecular imaging and radiopharmaceutical therapies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical Imaging, Biotechnology, Medical AI, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BAMF Health Comparables
Compare BAMF Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| United Theranostics | 84% | |
| Telix Pharmaceuticals | 69% | |
| SOFIE | 66% |
For institutional investors. Book with your work email.
BAMF Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 4, 2026 | ||||
| Grant | Feb 13, 2025 | ||||
| Series C | Aug 19, 2024 | ||||
| Grant | Jun 1, 2024 | ||||
| Series A | Dec 1, 2021 | ||||
Series B | Nov 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BAMF Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waséyabek Development Company | Series C, Series B |
| New Community Transformation Fund | Series A, Seed, Series B |
| Michigan Rise and Red Cedar Ventures | Series B |
| Michigan State University Research Foundation | Series A, Seed |
| Red Cedar Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$60M round closed.
- Apr 1, 2026
Features dual-cyclotron Radiopharmacy and Molecular Imaging Clinic.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
In 2025, BAMF Health, Inc. reaches $25M in revenue.
For institutional investors. Book with your work email.
BAMF Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BAMF Health's valuation, stock price, and market status.
Is BAMF Health a public or private company?
BAMF Health is a private company.
What is the current stock price of BAMF Health?
BAMF Health is a private company, so its shares have no public market price. Caplight tracks BAMF Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BAMF Health worth (valuation)?
Valuation information for BAMF Health is not publicly available.
Can I buy BAMF Health stock?
BAMF Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BAMF Health's last funding round?
BAMF Health's most recent funding round was Series B on May 4, 2026.
Who are the main investors in BAMF Health?
Key investors in BAMF Health include Waséyabek Development Company, New Community Transformation Fund, Michigan Rise and Red Cedar Ventures, Michigan State University Research Foundation, Red Cedar Ventures.
Will BAMF Health IPO soon?
No public IPO plans have been announced for BAMF Health.
How can I track BAMF Health secondary market activity?
Caplight tracks bids, offers, and trades in BAMF Health's shares on secondary markets.